Survival rates for many cancers have improved due to new treatments and earlier detection. Yet cases of some cancers, such as ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

The latest edition of an annual report finds new cases continue to rise and outcomes have worsened for some cancers.

An Alabama Senate committee unanimously approved a bill Wednesday morning that would require health insurance companies to ...

Ernie Strauss and Ronald Wakefield, who met through the patient navigation program of Northside Hospital, have built a ...

Treatment with Leuprorelin did not improve OS or disease-specific survival for patients with nonmetastatic, high-risk prostate cancer who have undetectable PSA levels, while causing more adverse ...

Hormone therapy is commonly combined with radiation therapy for prostate cancer, but patients are often unsure how long it should be continued and why. A new study published in JAMA Oncology from ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...

In this analysis, researchers aimed to evaluate the clinicopathologic characteristics, metastatic patterns, and survival outcomes in patients with metastatic prostate cancer and low-volume primary ...

The therapy is a highly advanced form of radiation therapy that uses charged particles in the form of a proton that that gets ...

The novel MEK inhibitor atebimetinib in combination with modified gemcitabine/nab-paclitaxel led to a 12-month overall ...

A few years ago, I had a patient who affectionately went by the name “Pops.” At 85 years young, he was full of life and juggling multiple health issues alongside prostate cancer, yet determined not to ...